CENTRIMAG

Watch this video to see the CentriMag Pump in action.

CentriMag Pump: Designed for Optimal Hemocompatibility^1,2

Driven by Full MagLev™ Flow Technology, the CentriMag™ Pump includes a free-floating magnetically levitated rotor for a contact-free environment. This innovative technology results in excellent hemodynamics, which can lead to minimized blood stagnation, friction and shear stress.^3,4

Addressing the broadest spectrum of clinical challenges

The CentriMag blood pump functions as:

• Part of an ECMO circuit for periods > 6 hours
• Extracorporeal bypass circuit for periods up to 30 days*, to support the left, right, or both ventricles of the heart

The CentriMag System includes both pediatric and adult pump options, producing flows up to 1.5 LPM for pediatric, and 10 LPM for adult.

Designed to meet individualized requirements

The CentriMag System offers freedom of choice. It fits seamlessly into custom circuit designs, and can be used with a variety of cannulation options.

*PMA approval for 30-day use of CentriMag System components include: CentriMag™ Pump, CentriMag™ Console, CentriMag™ Motor, Mag Monitor, Flow Probe, and CentriMag™ Drainage Cannula and CentriMag™ Return Cannula. Optional accessories include: CentriMag™ System Cart, CentriMag™ System Transporter and Pressure Transducer. PMA approval for 30-day use of CentriMag™ System excludes: PediMag™ Blood Pump and any other pediatric components or accessories.
**ECMO clearance for >6-hour use is indicated for the CentriMag™ Blood Pump to be used with: CentriMag™ Console, CentriMag™ Motor, Mag Monitor, and Flow Probe. Optional accessories include: CentriMag™ System Cart, CentriMag™ System Transporter and Pressure Transducer. ECMO clearance for the CentriMag™ Blood Pump is for adult use only.
† Approved for 30-day use
†† Cleared for >6-hour use.

References

1. John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, Lyle. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. http://dx.doi.org/10.1016/j.jtcvs.2007.01.085
2. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939. http://dx.doi.org/10.1016/j.jtcvs.2010.03.046
3. Aziz, T. A., Singh, G., Popjes, E., Stephenson, E., Mulvey, S., Pae, W., & El-Banayosy, A. (2010). Initial experience with CentriMag extracorporeal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. The Journal of Heart and Lung Transplantation, 29(1), 66-71. http://dx.doi.org/10.1016/j.healun.2009.08.025
4. Bhama, J. K., Kornos, R. L., Toyoda, Y., Teuteberg, J. J., McCurry, K. R., & Siegenthaler, M. P. (2009). Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. The Journal of Heart and Lung Transformation, 28(9), 971-976. https://www.jhltonline.org/article/S1053-2498(09)00238-1/fulltext
5. Takeda K, Garan AR, Ando M, et al. Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional CentriMag biventricular support configuration. Eur J Cardio-Thorac Surg. 2017;52:1055-1061.
6. Worku B, Pak S-W, van Patten D, et al. The CentriMag ventricular assist device in acute heart failure refractory to medical management. J Heart Lung Transplant. 2012;31:611-617.
7. Takayama H, Soni L, Kalesan B, et al. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail. 2014;7:799-806.